MLMarcelo Barreto Lopes

Marcelo Barreto Lopes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marcelo Barreto Lopes has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Racial and Gender Disparities Among Patients Treated for Intracranial Aneurysms: A Retrospective Cohort Study in a Tertiary Public Hospital in Latin America

    by Diana Lara Pinto de Santana, Marcelo Barreto Lopes, Giovanna Sabino Bezerra Corrêa, Pedro Henrique Mouty Rabello, Carlos Gilberto Carlotti, Eberval Gadelha Figueiredo

  • Open Access

    CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in a Prospective Cohort of Hemodialysis Patients of Predominantly African Ancestry: The PROHEMO

    by Gabriel Brayan Gutiérrez-Peredo, Andrea Jimena Gutiérrez-Peredo, Iris Montaño-Castellón, Marinho Marques da Silva Neto, Fernanda Albuquerque da Silva, Marcia Tereza Silva Martins, Cacia Mendes Matos, Jean Michell Correia Monteiro, Pedro Guimarães Silva, Gildete Barreto Lopes, et al.

    Background: Patients with chronic kidney disease undergoing maintenance hemodialysis (MHD) have an increased mortality. The CHA2DS2-VASc score, initially used for stroke prediction in atrial fibrillation, is relevant for various cardiovascular conditions. This study evaluates its effectiveness in predicting cardiovascular and all-cause mortality in MHD patients. Methods: Data are from the “Prospective Study of the Prognosis of Patients on Chronic Hemodialysis” (PROHEMO) in Salvador, Brazil. Patients were divided by CHA2DS2-VASc scores: ≤2 and >2. Cox regression estimated hazard ratios (HR) for death, both unadjusted and adjusted for confounders. We assessed the distribution of each score variable and its association with mortality. A modified CHA2DS2-VASc score was created due to the low percentage of patients over 75 (1.3%) and normotensive (4.6%). Results: A total of 237 patients (mean age 51.6 years; 57.0% male) were included in the study. There were 55 deaths, 21 from cardiovascular causes. For patients with a CHA2DS2-VASc score >2, the unadjusted hazard of all-cause mortality was doubled (HR = 2.05; 95% CI: 1.20, 3.49) compared to those with a score ≤2, and the risk for cardiovascular deaths was more than threefold (HR = 3.53; 95% CI: 1.46, 8.54). These ratios remained consistent after adjusting for covariates. In the most comprehensive Cox model, the HR for all-cause mortality was 2.43 (95% CI: 1.38, 4.23) and for cardiovascular mortality was 3.52 (95% CI: 1.40, 8.84), similar to results from the modified CHA2DS2-VASc score. Conclusions: The results support the CHA2DS2-VASc score as a practical tool for identifying MHD patients at higher risk of mortality, especially from cardiovascular causes.


  • Open Access

    The urine protein/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective study

    by Gabriel Brayan Gutiérrez-Peredo, Iris Montaño-Castellón, Andrea Jimena Gutiérrez-Peredo, Marcelo Barreto Lopes, Fernanda Pinheiro Martin Tapioca, Maria Gabriela Motta Guimaraes, Sony Montaño-Castellón, Sammara Azevedo Guedes, Fernanda Pita Mendes da Costa, Ricardo José Costa Mattoso, et al.

    The 24-h urine protein (24-hUP) excretion is the gold standard for evaluating proteinuria. This study aimed to evaluate the diagnostic efficacy of protein/creatinine ratio (PCR) for estimating 24-hUP at various levels of renal function and proteinuria levels. A cross-sectional study was conducted between December 2021 and December 2023 in Salvador, Bahia-Brazil, as an extension of previously published data from the TUNARI study. The study included 217 samples from 152 patients with various levels of renal function and proteinuria. PCR in isolated samples and 24-hUP were determined conventionally within a 24-h timeframe. Patients were classified into three groups according to the level of renal function (Group 1 = 10 to < 30 mL/min, Group 2 = 30–60 mL/min, and Group 3 = > 60 mL/min) and level of proteinuria (< 0.3 g/day, 0.3–3.5 g/day, and > 3.5 g/day). The data were analyzed using the Spearman correlation (rs), coefficient of determination (r2), Bland–Altman plots and receiver operating characteristic (ROC) curve. Likelihood ratios, positive (LR +), and negative (LR-) were derived from the sensitivity and specificity of PCR. Mean age was 41.5 ± 15.7 years, 61.8% were women, 36.8% Black and 52% Mixed-race. Glomerulopathies constituted 80.3%; 46.1% with lupus nephritis. Of the total urine samples, we observed a high correlation between PCR in the total sample of 24-hUP sample (rs = 0.86, p < 0.001) across different levels of renal function. However, agreement between PCR and 24-hUP was reduced at higher levels of proteinuria. The ROC analysis showed an AUC of 0.95 (95% CI = 0.92, 0.98), sensitivity of 91% and specificity of 86.5% (LR + 6.7; LR- 0.1), with an optimal cut-off of 0.77. These results were similar across renal function levels. Proteinuria ≤ 0.3 g/day showed a high sensitivity of 83.3% and specificity of 90%, with an area under (AUC) of 0.85 (95% CI = 0.71; 0.94). In the 24-hUP range > 0.3–3.5 g/day, the sensitivity was 64.1%, the specificity was 84.6%, and the AUC was 0.76 (95% CI = 0.67; 0.84), PCR detected all cases > 3.5 g/day. PCR is a suitable measure to be used as an indicator of 24-hUP at different levels of renal function, but may have limitations at higher levels of proteinuria. Analysis of PCR by proteinuria level found that agreement as well as sensitivity decreases at higher levels, but it maintains good specificity and is able to identify nephrotic range proteinuria.


  • Open Access

    #5292 BRAZILIAN SURVEY ON THE MANAGEMENT OF ACUTE KIDNEY INJURY AND RENAL REPLACEMENT THERAPIES

    by Mauricio Teixeira, Fernanda Coelho, Rogério Passos, Marcelo Lopes, Marcelo Silveira, Thiago Reis, Bruno Zawadzki

    Background and Aims: Acute kidney injury (AKI) diagnosis, management, the optimal prescription and delivery of renal replacement therapy (RRT) standards for best practice are lacking. The aim of this study was to explore the clinical approach to AKI and RRT in a broad population of Brazilian nephrologists. Method: A cross-sectional survey was distributed to all nephrologists from multiple centres of a Brazilian private hospital group. The responses of the participants on several aspects of AKI management and renal replacement therapy were analysed and detailed. Results: 97 (66%) nephrologists from 8 Brazilian states responded. 45% referred KDIGO 2 as the stage usually present at time of nephrologist consultation, and mean time for nephrology consultation after AKI diagnosis was 24-48h for 51% of answers. 85% reported creatinine as the only biomarker available for diagnosis, and only 24% reported any AKI alert system. Sepsis was reported as the most frequent etiology by 95%; kidney biopsy indication was considered in less than 10% of the evaluations by 94%. Fluid status assessment is described in Figure 1. The most common criteria for starting RRT was fluid overload (30%) followed by urine output reduction (26%), hyperkalemia (14%) and acidosis (17%). 62% of them usually use furosemide stress test before RRT indication. Seventy-seven percent of participants said that never use peritoneal dialysis in AKI patients, although its available for 44% of responders. Hypotension was the most frequent RRT complication for 91% responders, followed by coagulation of the system for 42% and catheter dysfunction for 33%. CRRT was available for 92% of participants and for 88% this is the RRT for patients using vasoactive drugs. 77% usually use regional anticoagulation with citrate. The most common starting dose is 26 to 30ml/Kg/h and the net ultrafiltration rate is 1,01-1,75 ml/Kg/h. There is no weaning protocol of RRT for 81%, but 90% use the urine output as a weaning tool. Thirty- nine percent said that RRT patients’ mortality stayed between 20 to 50%, and 36% had no information about mortality. Conclusion: In our survey, Nephrology consultation occurred after 24h and at KDIGO 2 stage. Early recognition of AKI is impeded by the use of serum creatinine as the only biomarker and the unavailability of AKI alerts. Fluid overload is the main reason for indicating RRT and nephrologists have expanded the use of non-invasive fluid status assessment methods others than physical examination. CRRT is the method of choice for unstable patients in this sample from private medical facilities, where almost all responders have access to CRRT. Effluent doses and net ultrafiltration rate were in accordance with the established in literature. Optimal timing for discontinuing RRT is still defined according to the physician's discretion. Standardization of AKI management and continuing education seem to be a fundamental aspect to anticipate the diagnosis, improve the therapeutic approach and bring better results for AKI patients.

  • Open Access

    Monitoring social distancing and SARS-CoV-2 transmission in Brazil using cell phone mobility data

    by Silvano Barbosa de Oliveira, Victor Bertollo Gomes Pôrto, Fabiana Ganem, Fabio Macedo Mendes, Maria Almiron, Wanderson Kleber de Oliveira, Francieli Fontana Sutile Tardetti Fantinato, Walquiria Aparecida Ferreira de Almeida, Abel Pereira de Macedo Borges, Hector Natan Batista Pinheiro, et al.

    Social distancing measures have emerged as the predominant intervention for containing the spread of COVID-19, but evaluating adherence and effectiveness remains a challenge. We assessed the relationship between aggregated mobility data collected from mobile phone users and the time-dependent reproduction number R(t), using severe acute respiratory illness (SARI) cases reported by São Paulo and Rio de Janeiro. We found that the proportion of individuals staying home all day (isolation index) had a strong inverse correlation with R(t) (rho<-0.7) and was predictive of COVID-19 transmissibility (p<0.0001). Furthermore, indexs of 46.7% had the highest accuracy (93.9%) to predict R(t) below one. This metric can be monitored in real time to assess adherence to social distancing measures and predict their effectiveness for controlling SARS-CoV-2 transmission. One Sentence Summary: Mobility data to monitoring social distancing in the COVID-19 outbreak